Loading...
Nutriband Inc (NTRB) is not a strong buy at this moment for a beginner investor with a long-term strategy. The lack of significant positive catalysts, combined with weak financial performance and no clear trading signals, suggests holding off on investment until more favorable conditions emerge.
The MACD is slightly positive, indicating mild bullish momentum, but it is contracting. RSI is neutral at 48.157, showing no clear overbought or oversold conditions. Moving averages are converging, and the stock is trading near its pivot point of 4.239, with resistance at 4.443 and support at 4.034. Overall, there is no strong technical signal for a buy.
NULL identified. No recent news or significant insider/hedge fund activity. MACD is slightly positive, but not strongly bullish.
Revenue dropped significantly by -46.41% YoY in the latest quarter (2026/Q3). Gross margin also declined by -33.06% YoY. No recent congress trading data or news to drive positive sentiment.
In 2026/Q3, revenue dropped significantly to 346,058 (-46.41% YoY). Net income improved to -3,872,367 (up 184.18% YoY), but it remains negative. EPS improved to -0.32 (up 166.67% YoY), but still negative. Gross margin dropped to 19.8 (-33.06% YoY). Overall, financial performance is weak with no clear growth trends.
No data available for analyst ratings or price target changes.
